Archive for the ‘phase II’ tag
Chart of the Day: Probability of success of clinical trials
For pharma, this is the curve that needs to be re-shaped:
Source: Morgan Stanley
Chart of the Day: Where is clinical research happening (therapeutic areas)?
Most clinical research is happening in oncology, CNS, and cardiovascular:
Source: Company research via Barclays Capital
Chart of the Day: Where is the clinical research happening (phase)?
Pre-phase II R&D accounts for about 35% of total R&D spending:
Source: PhRMA, 2009
Chart of the Day: How do clinical trial phases differ?
One unique aspect of the drug development pipeline (see previous Chart of the Day) is that there is a series of clinical trials conducted by pharmaceutical companies and CROs in a phased approach. University of Pittsburgh has compiled a convenient summary of each phase to better understand the differences among clinical trial phases (link here):
Chart of the day: Drug approval pipeline
Always nice to see helpful illustrations of the time required and probability of success of compounds receiving FDA approval:
It’s a reminder of TrialDox’s mission to minimize the time to complete clinical studies and get safe and effective products to the market faster.